| Name | Title | Contact Details |
|---|
QuVa Pharma, Inc. is a newly-formed national platform for sterile compounding pharmacy services led by two experienced industry executives that has received a majority equity commitment from Bain Capital Private Equity to support the company’s creation and expansion plans. As part of its formation, QuVa Pharma has acquired the assets of the compounding services division of a company leader in the field of parenteral and management services, including its state-of-the-art 503B manufacturing facility in Sugar Land, Texas.
Northern Arizona Regional Behavioral Health Authority (NARBHA) was founded in 1967. It is a private, not-for-profit managed care corporation designated by the Arizona Department of Health Services as being responsible for the planning, implementation, funding, monitoring and administration of publicly funded comprehensive behavioral health services in Northern Arizona. NARBHA serves over 700,000 people throughout 62,000 square miles (or ½ of the state) of northern Arizona, including the Hopi Reservation. NARBHA subcontracts with ten Responsible Agencies (RAs), over 70 additional behavioral health providers, and operated under Memorandums of Understanding (MOU) with ten Native American tribes, offering choice of services to members throughout northern Arizona. NARBHA contracts with NAZCARE, Recovery Innovations of Arizona (RIAZ), and MIKID to offer peer and family support programs and services. Consumer/ family involvement is included on eight standing NARBHA and numerous ad hoc NARBHA Committees and Workgroups.
O. I. Medical is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mr. Gallagher is Senior Vice President & Chief Financial Officer at RRD International, LLC. Mr. Gallagher provides strategic, operational, and financial leadership to RRD. His primary responsibilities are planning, implementing, managing, and controlling all financial-related activities including the development of financial and operational strategies. Mr. Gallagher has over 20 years of finance experience in the biopharma industry with both multi-national corporations and commercial-stage public biotechnology companies. He has an extensive background in all areas of corporate controllership, including financial planning & analysis, cost control, management accounting, corporate administration, and systems implementation. He has supported all aspects of product development and commercialization, including the negotiation and execution of licensing and collaboration agreements with major pharma partners. Mr. Gallagher served previously as Vice President of Finance for Optimer Pharmaceuticals and, prior to that, as Senior Director of Finance and Corporate Controller for Adolor Corporation. He had a central role in the sale of both companies. Mr. Gallagher spent the first 10 years of his career with Therakos, Inc. (a Johnson & Johnson company) and Merck & Co., Inc. He received his BS in Finance from The Pennsylvania State University and is an active Certified Management Accountant (CMA).
CliniComp is a global provider of Electronic Health Record (EHR) software and solutions that has enjoyed an unrivaled track record of performance and reliability in the most complex high acuity hospital environments for decades. Starting in 2014 CliniComp EHR extends the scope of coverage to Outpatient and Ancillaries such as Pharmacy, Radiology, and clinical laboratory information systems. This fully-integrated one stop expanded offering guarantees seamless CPOE and order/results management as well as transparent patient record viewing across all patient environments, distinct sites and time. Every Patient. Everywhere. For Life. The CCI system is certified for Stage 2 Meaningful Use and is currently supported internationally.